A recent report from the Brookings Private Sector Global Health R&D Projectoutlines just how vital private investment has been to global health progress, and points to a future in which it will be even more critical.

Breast cancer is 1 of the most common—and deadly—cancers in sub-Saharan Africa: Fewer than 1/2 of women diagnosed are alive after 5 years, compared with 90% in the US.

Using liquid nitrogen and advanced microscope techniques, a team of international scientists was able to observe precisely how malaria attacks red blood cells—and generate new ideas about how to combat them.The study, which will be published in this week’s issue of…

The 2,000-year-old remains of a Roman have scientists concluding that malaria was endemic on the Mediterranean Island of Sardinia hundreds of years earlier than previously believed. Of note—how they arrived at the conclusion.Extracting DNA of malaria from remains is…

With President Trump’s proposed cuts to global health programs looming, a new Global Health Technologies Coalition report argues why US investment in such research and development is a smart move.   Between 2007 and 2015, the US invested nearly $14 billion in global health…

The Global Health Innovative Technology Fund announced that it has secured $200 million—double its initial investment—for Japanese research and development on neglected diseases.   The funding, GHIT says, will boost the development of new medicines, vaccines and diagnostics…

A “mini-brain” model has confirmed the Zika virus’s ability to cause microcephaly by infecting neural progenitor cells, according to Johns Hopkins scientists.